101 related articles for article (PubMed ID: 8021497)
1. MHC class I molecule-restricted presentation of viral antigen in beta 2-microglobulin-deficient mice.
Lehmann-Grube F; Dralle H; Utermöhlen O; Löhler J
J Immunol; 1994 Jul; 153(2):595-603. PubMed ID: 8021497
[TBL] [Abstract][Full Text] [Related]
2. Control of acute infection with lymphocytic choriomeningitis virus in mice that cannot present an immunodominant viral cytotoxic T lymphocyte epitope.
Gegin C; Lehmann-Grube F
J Immunol; 1992 Nov; 149(10):3331-8. PubMed ID: 1385522
[TBL] [Abstract][Full Text] [Related]
3. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
Zügel U; Schoel B; Kaufmann SH
J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
[TBL] [Abstract][Full Text] [Related]
4. Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells.
Hou S; Doherty PC; Zijlstra M; Jaenisch R; Katz JM
J Immunol; 1992 Aug; 149(4):1319-25. PubMed ID: 1354233
[TBL] [Abstract][Full Text] [Related]
5. Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin.
Rodriguez M; Dunkel AJ; Thiemann RL; Leibowitz J; Zijlstra M; Jaenisch R
J Immunol; 1993 Jul; 151(1):266-76. PubMed ID: 8326128
[TBL] [Abstract][Full Text] [Related]
6. CD4+ and CD8+ alpha beta, and gamma delta T cells are cytotoxic effector cells of beta 2-microglobulin-deficient mice against cells having normal MHC class I expression.
Udaka K; Marusić-Galesić S; Walden P
J Immunol; 1994 Sep; 153(6):2843-50. PubMed ID: 7915743
[TBL] [Abstract][Full Text] [Related]
7. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
8. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
White KL; Snyder HL; Krzych U
J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
[TBL] [Abstract][Full Text] [Related]
9. Induction of peptide-specific CD8+ CTL clones in beta 2-microglobulin-deficient mice.
Cook JR; Solheim JC; Connolly JM; Hansen TH
J Immunol; 1995 Jan; 154(1):47-57. PubMed ID: 7995959
[TBL] [Abstract][Full Text] [Related]
10. Murine hepatitis caused by lymphocytic choriomeningitis virus. II. Cells involved in pathogenesis.
Gossmann J; Lohler J; Utermohlen O; Lehmann-Grube F
Lab Invest; 1995 May; 72(5):559-70. PubMed ID: 7745950
[TBL] [Abstract][Full Text] [Related]
11. Clearance of Sendai virus by CD8+ T cells requires direct targeting to virus-infected epithelium.
Hou S; Doherty PC
Eur J Immunol; 1995 Jan; 25(1):111-6. PubMed ID: 7843219
[TBL] [Abstract][Full Text] [Related]
12. Development and antigen specificity of CD8+ cytotoxic T lymphocytes in beta 2-microglobulin-negative, MHC class I-deficient mice in response to immunization with tumor cells.
Apasov SG; Sitkovsky MV
J Immunol; 1994 Mar; 152(5):2087-97. PubMed ID: 8133027
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection.
Tarleton RL; Koller BH; Latour A; Postan M
Nature; 1992 Mar; 356(6367):338-40. PubMed ID: 1549177
[TBL] [Abstract][Full Text] [Related]
14. Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway.
Canaday DH; Ziebold C; Noss EH; Chervenak KA; Harding CV; Boom WH
J Immunol; 1999 Jan; 162(1):372-9. PubMed ID: 9886409
[TBL] [Abstract][Full Text] [Related]
15. Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation.
Hermans IF; Ritchie DS; Daish A; Yang J; Kehry MR; Ronchese F
J Immunol; 1999 Jul; 163(1):77-81. PubMed ID: 10384102
[TBL] [Abstract][Full Text] [Related]
16. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice.
Thomsen AR; Johansen J; Marker O; Christensen JP
J Immunol; 1996 Oct; 157(7):3074-80. PubMed ID: 8816417
[TBL] [Abstract][Full Text] [Related]
17. Altered kinetics of CD4+ T cell proliferation and interferon-gamma production in the absence of CD8+ T lymphocytes in virus-infected beta2-microglobulin-deficient mice.
Vikingsson A; Pederson K; Muller D
Cell Immunol; 1996 Nov; 173(2):261-8. PubMed ID: 8912885
[TBL] [Abstract][Full Text] [Related]
18. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer.
Bristol JA; Schlom J; Abrams SI
Cell Immunol; 1999 May; 194(1):78-89. PubMed ID: 10357883
[TBL] [Abstract][Full Text] [Related]
19. Construction of bioactive chimeric MHC class I tetramer by expression and purification of human-murine chimeric MHC heavy chain and beta(2)m as a fusion protein in Escherichia coli.
Ren D; Wang F; He X; Jiang L; Li D; Ying H; Sun S
Protein Expr Purif; 2006 Dec; 50(2):171-8. PubMed ID: 17046278
[TBL] [Abstract][Full Text] [Related]
20. Intestinal intraepithelial lymphocytes respond to systemic lymphocytic choriomeningitis virus infection.
Sydora BC; Jamieson BD; Ahmed R; Kronenberg M
Cell Immunol; 1996 Feb; 167(2):161-9. PubMed ID: 8603424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
